BiotechTube
Home/Quince Therapeutics/Christopher Krueger, J.D.
CK

Christopher Krueger, J.D.

Chief Business Officer and General Counsel

Quince Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesInflammatory Diseases

Quince Therapeutics Pipeline

DrugIndicationPhase
EQ101Alzheimer's DiseasePhase 1

Leadership Team at Quince Therapeutics

MD
Michael D. K. Bigham
Chairman of the Board
DT
Dirk Thye, M.D.
Chief Executive Officer and Director
EL
Erin L. Bales
Chief Commercial Officer
HE
Halley E. Gilbert
Chief Operating Officer
SH
Sharon Hall
Chief Financial Officer (Interim)
CC
Casey C. Lynch
Co-Founder and Director
SL
Stephen L. Dominy, M.D.
Co-Founder and Director
RD
Robert D. Hoffman
Director
WD
William D. Young
Director
AL
Alison Lawton
Director
View full Quince Therapeutics profile